SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life secures four product patents

19 Aug 2011 Evaluate

Suven Life Sciences has won four product patents for its new chemical entities designed for treatment of neurodegenerative diseases. These were granted in Europe, Sri Lanka and South Korea for compounds that are being developed as therapeutic agents for Alzheimer's disease, Parkinson's and Schizophrenia, among others.

The cognitive disorders for which these drugs would be developed were a $ 30-billion market globally. With this, the biopharma company has a total of 11 granted patents from Europe, eight from Sri Lanka and five from South Korea. These patents are its exclusive intellectual property, achieved through internal research. Products developed out of these inventions may be outlicensed at different phases of clinical development.crackcrack

Suven Life Sciences Share Price

195.90 -0.10 (-0.05%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×